<DOC>
	<DOCNO>NCT01938339</DOCNO>
	<brief_summary>To development clinical assessment technique use multi-radiotracer positron emission tomography/magnetic resonance ( PET/MR ) prostate cancer - establish optimal imaging technique PET/MR use multiple radioactive tracer prostate cancer - establish image biomarker use PET/MR clinical assessment prostate cancer early detection recurrent prostate cancer</brief_summary>
	<brief_title>Development Clinical Assessment Technique Using Multi-radiotracer PET/MR Prostate Cancer</brief_title>
	<detailed_description>To establish optimal imaging technique PET/MR use multiple radioactive tracer prostate cancer - Recruiting 30 patient prostate cancer ahead radical prostatectomy - PET/MR use 18F-choline dedicated prostate MRI patient - PET/MR use 18fluoride ( F ) -fluorodeoxyglucose ( FDG ) patient 2-7 day - PET/CT use 18F-FDG patient immediate 18F-FDG PET/MR - outcome assessment : comparison scan time , image quality , tumor detection rate , standardize uptake value lesion - establish optimal imaging technique prostate PET/MR To establish image biomarker use PET/MR clinical assessment prostate cancer - comparison finding PET/MR , MRI PET/CT pathological mapping radical prostatectomy - outcome assessment : accuracy PET/MR localization stag prostate cancer compare MRI PET/CT To establish image biomarker use PET/MR early detection recurrent prostate cancer - Recruiting 15 patient recurrent prostate cancer treat surgery , hormone , radiation therapy - Recruiting 15 patient treated prostate cancer without recurrence - PET/MR use 18F-choline dedicated prostate MRI patient - PET/MR use 18F-FDG patient 2-7 day - PET/CT use 18F-FDG patient immediate 18F-FDG PET/MR - comparison finding PET/MR , MRI , PET/CT clinical data two patient group without recurrent prostate cancer - outcome assessment : accuracy PET/MR early detection localization recurrent prostate cancer compare MRI PET/CT</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>patient prostate cancer treatment patient prostate cancer treat patient prostate cancer recurrent patient contraindication MRI Patient severe renal impairment</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>prostate cancer</keyword>
	<keyword>MRI</keyword>
	<keyword>PET</keyword>
</DOC>